DI-068 Beliefs, knowledge and expectations about medicines and pharmacists in asthma and pulmonary arterial hypertension patients: preliminary results
https://ejhp.bmj.com/content/22/Suppl_1/A101.1
Type de document :
Compte-rendu et recension critique d'ouvrage
Titre :
DI-068 Beliefs, knowledge and expectations about medicines and pharmacists in asthma and pulmonary arterial hypertension patients: preliminary results
https://ejhp.bmj.com/content/22/Suppl_1/A101.1
https://ejhp.bmj.com/content/22/Suppl_1/A101.1
Auteur(s) :
Renet, Sophie [Auteur]
CREF: Équipe Apprenance et Formation des Adultes
Chaumais, Marie-Camille [Auteur]
Las Vergnas, Olivier [Auteur]
CREF: Équipe Apprenance et Formation des Adultes
Trigone-CIREL
Centre Interuniversitaire de Recherche en Education de Lille - ULR 4354 [CIREL]
Humbert, Marc [Auteur]
Hypertension pulmonaire : physiopathologie et innovation thérapeutique [HPPIT]
Rieutord, André [Auteur]
CREF: Équipe Apprenance et Formation des Adultes
Chaumais, Marie-Camille [Auteur]
Las Vergnas, Olivier [Auteur]
CREF: Équipe Apprenance et Formation des Adultes
Trigone-CIREL
Centre Interuniversitaire de Recherche en Education de Lille - ULR 4354 [CIREL]
Humbert, Marc [Auteur]
Hypertension pulmonaire : physiopathologie et innovation thérapeutique [HPPIT]
Rieutord, André [Auteur]
Titre de la revue :
European Journal of Hospital Pharmacy
Pagination :
A101
Éditeur :
BMJ Group
Date de publication :
2015-03-24
ISSN :
2047-9956
Mot(s)-clé(s) en anglais :
Beliefs
knowledge
pharmacists
asthma
pulmonary arterial hypertension
knowledge
pharmacists
asthma
pulmonary arterial hypertension
Discipline(s) HAL :
Sciences de l'Homme et Société/Education
Sciences du Vivant [q-bio]/Santé publique et épidémiologie
Sciences de l'Homme et Société/Méthodes et statistiques
Sciences du Vivant [q-bio]/Santé publique et épidémiologie
Sciences de l'Homme et Société/Méthodes et statistiques
Résumé en anglais : [en]
Background Chronic diseases have changed the management of patients and their status, to move toward a new “patient-healthcare providers” partnership. Asthma and pulmonary arterial hypertension (PAH) are two chronic thoracic ...
Lire la suite >Background Chronic diseases have changed the management of patients and their status, to move toward a new “patient-healthcare providers” partnership. Asthma and pulmonary arterial hypertension (PAH) are two chronic thoracic diseases with differences in terms of prevalence and drug delivery process. Little is known regarding patient’s beliefs (B), knowledge (K) and expectations (E) of their illness, medicines and healthcare providers, despite these parameters influencing their adherence, behaviour and outcomes.Purpose To gain detailed insight into B, K and E of medicines and pharmacists from asthma or PAH patients.Material and methods For this observational prospective monocentric study, an interview guide was designed and validated to perform the semi-structured interviews (SSI). Each interview was recorded and fully transcribed. An inductive approach was conducted for the remaining text to inventory verbatim. All were classified according to the key ideas to describe B, K, E for each population.Results SSI were conducted with 14 patients (5 asthma–9 PAH) (mean duration 37 ± 10 min) from December 2013 to April 2014. Medicines were perceived as a “necessity” (6 PAH–3 asthma), a “constraint” (3 PAH) or “poisons” (2 asthma). Three asthma patients didn’t perceive the necessity of corticosteroids but all judged salbutamol and terbutaline as vital. Four PAH patients noticed few people and healthcare professionals who knew PAH and its management. Pharmacists could sometimes be perceived only as “retailers” (2 PAH–3 asthma), “advisors” (3 PAH) or associated with “medicines” (2 PAH–2 asthma). Tasks of pharmacists weren’t well known and defined (5 PAH–4 asthma).Conclusion Medicines and pharmacists were perceived differently depending on asthma or PAH patients. The ignorance about “what exactly pharmacists do” makes their role ambiguous for the patients leading to difficulties in describing their expectations of pharmaceutical care. More interviews are warranted to improve the B, K, E description of our populations.Lire moins >
Lire la suite >Background Chronic diseases have changed the management of patients and their status, to move toward a new “patient-healthcare providers” partnership. Asthma and pulmonary arterial hypertension (PAH) are two chronic thoracic diseases with differences in terms of prevalence and drug delivery process. Little is known regarding patient’s beliefs (B), knowledge (K) and expectations (E) of their illness, medicines and healthcare providers, despite these parameters influencing their adherence, behaviour and outcomes.Purpose To gain detailed insight into B, K and E of medicines and pharmacists from asthma or PAH patients.Material and methods For this observational prospective monocentric study, an interview guide was designed and validated to perform the semi-structured interviews (SSI). Each interview was recorded and fully transcribed. An inductive approach was conducted for the remaining text to inventory verbatim. All were classified according to the key ideas to describe B, K, E for each population.Results SSI were conducted with 14 patients (5 asthma–9 PAH) (mean duration 37 ± 10 min) from December 2013 to April 2014. Medicines were perceived as a “necessity” (6 PAH–3 asthma), a “constraint” (3 PAH) or “poisons” (2 asthma). Three asthma patients didn’t perceive the necessity of corticosteroids but all judged salbutamol and terbutaline as vital. Four PAH patients noticed few people and healthcare professionals who knew PAH and its management. Pharmacists could sometimes be perceived only as “retailers” (2 PAH–3 asthma), “advisors” (3 PAH) or associated with “medicines” (2 PAH–2 asthma). Tasks of pharmacists weren’t well known and defined (5 PAH–4 asthma).Conclusion Medicines and pharmacists were perceived differently depending on asthma or PAH patients. The ignorance about “what exactly pharmacists do” makes their role ambiguous for the patients leading to difficulties in describing their expectations of pharmaceutical care. More interviews are warranted to improve the B, K, E description of our populations.Lire moins >
Langue :
Anglais
Vulgarisation :
Non
Source :